Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,570 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
McLennan SV, Wang XY, Moreno V, Yue DK, Twigg SM. McLennan SV, et al. Among authors: wang xy. Endocrinology. 2004 Dec;145(12):5646-55. doi: 10.1210/en.2004-0436. Epub 2004 Sep 2. Endocrinology. 2004. PMID: 15345671
Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance.
Wang XY, Sun J, Wang C, France M, Sheil AG. Wang XY, et al. Among authors: wang c. Transplantation. 2001 Jan 15;71(1):102-11. doi: 10.1097/00007890-200101150-00017. Transplantation. 2001. PMID: 11211174
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
Wang XY, Martiniello-Wilks R, Shaw JM, Ho T, Coulston N, Cooke-Yarborough C, Molloy PL, Cameron F, Moghaddam M, Lockett TJ, Webster LK, Smith IK, Both GW, Russell PJ. Wang XY, et al. Gene Ther. 2004 Nov;11(21):1559-67. doi: 10.1038/sj.gt.3302308. Gene Ther. 2004. PMID: 15343359
Impact of STAT3 inhibition on survival of osteosarcoma cell lines.
Wang X, Goldstein D, Crowe PJ, Yang JL. Wang X, et al. Anticancer Res. 2014 Nov;34(11):6537-45. Anticancer Res. 2014. PMID: 25368256
Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell lines.
Wang X, Goldstein D, Crowe PJ, Yang JL. Wang X, et al. Int J Oncol. 2018 Jun;52(6):2143-2154. doi: 10.3892/ijo.2018.4337. Epub 2018 Mar 27. Int J Oncol. 2018. PMID: 29620166
Molecular chemotherapy and chemotherapy: a new front against late-stage hormone-refractory prostate cancer.
Singh PP, Joshi S, Russell PJ, Verma ND, Wang X, Khatri A. Singh PP, et al. Clin Cancer Res. 2011 Jun 15;17(12):4006-18. doi: 10.1158/1078-0432.CCR-11-0248. Epub 2011 Apr 29. Clin Cancer Res. 2011. PMID: 21531822
The Potential of panHER Inhibition in Cancer.
Wang X, Batty KM, Crowe PJ, Goldstein D, Yang JL. Wang X, et al. Front Oncol. 2015 Jan 28;5:2. doi: 10.3389/fonc.2015.00002. eCollection 2015. Front Oncol. 2015. PMID: 25674538 Free PMC article. Review.
Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence.
Wang X, Goldstein D, Crowe PJ, Yang JL. Wang X, et al. Onco Targets Ther. 2016 Sep 6;9:5461-73. doi: 10.2147/OTT.S94745. eCollection 2016. Onco Targets Ther. 2016. PMID: 27660463 Free PMC article. Review.
Carbon-Coated Gold Nanorods: A Facile Route to Biocompatible Materials for Photothermal Applications.
Kaneti YV, Chen C, Liu M, Wang X, Yang JL, Taylor RA, Jiang X, Yu A. Kaneti YV, et al. ACS Appl Mater Interfaces. 2015 Nov 25;7(46):25658-68. doi: 10.1021/acsami.5b07975. Epub 2015 Nov 13. ACS Appl Mater Interfaces. 2015. PMID: 26535913
The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas.
Wang X, Yeo RX, Hogg PJ, Goldstein D, Crowe P, Dilda PJ, Yang JL. Wang X, et al. Oncotarget. 2020 Jan 7;11(1):46-61. doi: 10.18632/oncotarget.27416. eCollection 2020 Jan 7. Oncotarget. 2020. PMID: 32002123 Free PMC article.
3,570 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback